Foundation Fighting Blindness Retinal Degeneration Fund

Insider Reports History

Location
Raleigh, NC
Signature
Foundation Fighting Blindness Retinal Degeneration Fund, By: /s/ Lorna A. Knick, Attorney-in-Fact for Russell Kelley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Foundation Fighting Blindness Retinal Degeneration Fund:

Company Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Director, Other* Common Stock 5,492,171 $11,808,167 $2.15 09 Dec 2025 Direct
Opus Genetics, Inc. Director, Other* Series A Non-Voting Convertible Preferred Stock 0 05 May 2025 Direct

Insider Reports Filed by Foundation Fighting Blindness Retinal Degeneration Fund

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IRD Opus Genetics, Inc. 09 Dec 2025 1 -$8,600,000 4 Director, Other* 11 Dec 2025, 17:35
IRD Opus Genetics, Inc. 05 May 2025 2 $0 4 Director, Other*, 10%+ Owner 06 May 2025, 18:05
IRD Opus Genetics, Inc. 22 Oct 2024 0 $0 3 Director, Other* 29 Oct 2024, 17:10